Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 09:37 am Purchase |
2024-09-30 | 13G | Savara Inc. SVRA |
Adage Capital Management L.P. | 6,753,701 4.100% |
6,753,701![]() (New Position) |
Filing History |
2024-11-12 09:37 am Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Adage Capital Management L.P. | 528,937 4.390% |
528,937![]() (New Position) |
Filing History |
2024-11-12 09:37 am Purchase |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
Adage Capital Management L.P. | 2,000,594 4.580% |
2,000,594![]() (New Position) |
Filing History |
2024-11-12 09:36 am Purchase |
2024-09-30 | 13G | Perella Weinberg Partners PWP |
Adage Capital Management L.P. | 1,037,615 1.900% |
1,037,615![]() (New Position) |
Filing History |
2024-11-12 09:36 am Purchase |
2024-09-30 | 13G | Amalgamated Financial Corp. AMAL |
Adage Capital Management L.P. | 716,262 2.340% |
716,262![]() (New Position) |
Filing History |
2024-11-12 09:36 am Purchase |
2024-09-30 | 13G | Guild Holdings Company GHLD |
Adage Capital Management L.P. | 597,110 2.840% |
597,110![]() (New Position) |
Filing History |
2024-11-12 09:35 am Unchanged |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Adage Capital Management L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
2024-11-12 09:35 am Purchase |
2024-09-30 | 13G | Rezolute, Inc. RZLT |
Adage Capital Management L.P. | 2,842,163 4.910% |
2,842,163![]() (New Position) |
Filing History |
2024-11-12 09:35 am Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Adage Capital Management L.P. | 854,083 4.810% |
854,083![]() (New Position) |
Filing History |
2024-11-12 09:34 am Purchase |
2024-09-30 | 13G | Nkarta, Inc. NKTX |
Adage Capital Management L.P. | 3,600,000 5.100% |
3,600,000![]() (New Position) |
Filing History |
2024-11-12 09:34 am Purchase |
2024-09-30 | 13G | Sutro Biopharma, Inc. STRO |
Adage Capital Management L.P. | 2,250,132 2.750% |
2,250,132![]() (New Position) |
Filing History |
2024-11-12 09:34 am Purchase |
2024-09-30 | 13G | Veru Inc. VERU |
Adage Capital Management L.P. | 7,861,111 5.370% |
7,861,111![]() (New Position) |
Filing History |
2024-11-12 09:34 am Purchase |
2024-09-30 | 13G | Cabaletta Bio, Inc. CABA |
Adage Capital Management L.P. | 3,634,475 7.430% |
3,634,475![]() (New Position) |
Filing History |
2024-11-12 09:34 am Purchase |
2024-09-30 | 13G | Wave Life Sciences Ltd. WVE |
Adage Capital Management L.P. | 9,703,351 6.660% |
9,703,351![]() (New Position) |
Filing History |
2024-11-12 09:34 am Unchanged |
2024-09-30 | 13G | Vinci Partners Investments Ltd. VINP |
Adage Capital Management L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
2024-11-12 09:33 am Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 3,791,420 7.080% |
-1,364,879![]() (-26.47%) |
Filing History |
2024-11-12 09:33 am Purchase |
2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO |
Adage Capital Management L.P. | 3,322,146 8.550% |
3,322,146![]() (New Position) |
Filing History |
2024-11-12 09:32 am Purchase |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
Adage Capital Management L.P. | 4,881,125 9.840% |
4,881,125![]() (New Position) |
Filing History |
2024-11-12 09:32 am Purchase |
2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX |
Adage Capital Management L.P. | 369,097 9.990% |
369,097![]() (New Position) |
Filing History |
2024-11-12 09:32 am Purchase |
2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX |
Adage Capital Management L.P. | 8,850,000 5.840% |
8,850,000![]() (New Position) |
Filing History |